Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,999,310
+$8,099,430 QoQ
Shares Held
152,592
+105.3% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#109
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Sep 30, 2025CallValue
$5,496
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. CYTK ranks #22 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in CYTK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,999,310 | 152,592 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,899,880 | 74,342 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $10,265,266 | 161,556 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,496 | 100 | Call | Defined | 2025-11-13 | |
| 2025-09-30 | $5,356,398 | 97,460 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,150,363 | 95,350 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,972,692 | 73,966 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,470,704 | 73,782 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,037,793 | 57,534 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,931,569 | 54,108 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,850,951 | 40,664 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $3,075,269 | 36,834 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,487,306 | 84,430 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,348,898 | 102,664 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,585,442 | 73,471 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,139,954 | 24,879 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,151,266 | 23,762 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $962,485 | 24,497 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,005,699 | 108,821 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,395,576 | 118,376 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,956,876 | 82,733 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $851,641 | 43,034 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,908,668 | 82,058 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,281,202 | 157,902 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,672,908 | 123,460 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,113,218 | 132,084 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,443,460 | 122,431 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||